"Invisible Man" References

May 1, 2006 - Natural Products Industry INSIDER

"Invisible Man" References

1. Haag M. "Essential fatty acids and the brain." Can J Psychiatry. 48, 3:195-203, 2003. www.cpa-apc.org

2. Favrelere J et al. "Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus." Neurobiol Aging. 21, 5:653-60, 2000. www.sciencedirect.com

3. Favreliere S et al. "DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus." Neurobiol Aging. 2003 24, 2:233-43.www.sciencedirect.com

4. Alves CS et al. "Phosphatidylserine reverses reserpine-induced amnesia."Eur J Pharmacol. 404, 1-2:161-7, 2000.www.sciencedirect.com

5. Mellott TJ et al. " Prenatal choline supplementation advances hippocampal development and enhances MAPK and CREB activation." FASEB J. 2004 18, 3:545-7, 2004. www.fasebj.org

6. Abad-Santos F et al. "[Treatment of mild cognitive impairment: value of citicoline]." Rev Neurol. 1-15;35, 7:675-82, 2002.www.revneurol.com

7. Wang R et al. "Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease." Neurosignals. 14, (1-2):71-82, 2005. http://content.karger.com/

8. Gray SL et al. "Is antioxidant use protective of cognitive function in the community-dwelling elderly?" Am J Geriatr. Pharmacother. 1, 1:3-10, 2003.

9. Laurin D et al. "Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study." Am J Epidemiol. 159, 10:959-67, 2004. www.aje.oupjournals.org

10. Morris MC et al. "Vitamin E and cognitive decline in older persons." Arch Neurol. 59, 7:1125-32, 2002. http://archneur.ama-assn.org

11. Pakiasamy AR et al. "Effect of L-carnitine on nucleic acid status of aged rat brain." Exper Neurol. 191, 1:33-40, 2005. http://www.sciencedirect.com/science/journal/00144886

12. Pettegrew JW, Levine J, McClure RJ. "Acetyl-L-carnitine physical-chemical, metabolic and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression." Mol Psychiatry. 5, 6:616-32, 2000.

13. Romay CH et al. "C-phycocyanin: a biliprotein with antioxidant, anti-inflammatory and neuroprotective effects." Curr Protein Pept Sci. 4, 3:207-16, 2003.

14. Gemma C et al. "Diets enriched in foods with high antioxidant activity reverse age-induced decreases in cerebellar beta-adrenergic function and increases in proinflammatory cytokines." J Neurosci. Jul 15;22, 14:6114-20, 2002. www.jneurosci.org

15. Upasani CD et al. "Protective effect of Spirulina on lead induced deleterious changes in the lipid peroxidation and endogenous antioxidants in rats." Phytother Res. 17, 4:330-4, 2003.http://www3.interscience.wiley.com

16. Kuriyama S et al. "Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project." Amer J Clin Nutr. 83, 2, 355-61, 2006. www.ajcn.org

17. Choi YT et al. "The green tea polyphenol, (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons."Life Sci. 70, 5:603-14, 2001. www.sciencedirect.com

18. Lian XY et al. "Protective effects of ginseng components in a rodent model of neurodegeneration." Ann Neurol. 57, 5:642-8, 2005.http://www3.interscience.wiley.com

19.Zhong Z et al. "[Protective effects of Panax notoginseng saponins against pathological lesion of cholinergic neuron in rat model with Alzheimer's disease]" Zhong Yao Cai. 28, 2:119-22, 2005.

20. Bao HY et al. "Memory enhancing and neuroprotective effects of selected ginsenosides." Arch Pharm Res. 28, 3:335-42, 2005.

21. Birks J et al. "Ginkgo Biloba for cognitive impairment and dementia." The Cochrane Database of Systematic Reviews, Issue 3, 2005.www.cochrane.org

22. Allain H et al. " Effect of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects." Clin Ther. 1993 May-Jun;15(3):549-58. www.clinicaltherapeutics.com

23. Subhan Z et al. "Psychopharmacological effects of vinpocetine in normal healthy volunteers." Eur J Clin Pharmacol. 28, 5:567-71, 1985.www.springerlink.com

24. Szatmari SZ et al. "Vinpocetine for cognitive impairment and dementia." Cochrane Database Syst Rev. 1:CD003119, 2003.www.medlib.com/spi/cdsr.htm

25. Khan A et al. "Cinnamon improves glucose and lipids of people with type II diabetes." . 26, 12: 3215-8, 2003.http://care.diabetesjournals.org/

26. Hayashi T et al. "Ellagitannins from Lagerstroemia speciosa as activators of glucose transport in fat cells." Planta Med. 68, 2:173-5, 2002.

27. Ahmad N et al. "Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients." Bangladesh Medical Research Council Bulletin. 25, 1:11-3, 1999.

29. Ananthan R et al. "Effect of Gymnema montanum on blood glucose, plasma insulin, and carbohydrate metabolic enzymes in alloxan-induced diabetic rats."J Med Foodd. 6, 1:43-9, 2003.

Life Sci. 75, 21:2505-13, 2004. www.elsevier.com

31. Spadea L et al. "Treatment of vascular retinopathies with Pycnogenol." Phytother Res. 15, 3:219-23, 2001.www3.interscience.wiley.com

32. Gregersen S et al. "Antihyperglycemic effects of stevioside in Type 2 diabetic subjects. Metabolism. 53, 1:73-6, 2004.www.journals.elsevierhealth.com

33. Jeppesen PB et al. Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat. Metabolism. 52, 3:372-8, 2003.

34. Liese AD et al. " Dietary glycemic index and glycemic load, carbohydrate and fiber intake, and measures of insulin sensitivity, secretion, and adiposity in the Insulin Resistance Atherosclerosis Study." Diabetes Care. 28, 12:2832-8, 2005.

35. Brennan CS et al. "Dietary fibre, glycaemic response, and diabetes." Mol Nutr Food Res. 49, 6:560-70, 2005..

J Am Coll Nutr. 23, 1:5-17, 2004.

37. Jenkins AL et al. "Depression of the glycemic index by high levels of beta-glucan fiber in two functional foods tested in type 2 diabetes." Eur J Clin Nutr. 56, 7:622-8, 2002. www.nature.com

38. Wursch P et al. "The role of viscous soluble fiber in the metabolic control of diabetes. A review with special emphasis on cereals rich in beta-glucan."Diabetes Caree. 20, 11:1774-80, 1997.

Nutr, Metab, Cardiovasc Dis Res. 15, 4:255-261, 2005.www.sciencedirect.com

40. Proprietary study. Property of Cargill. 2005..

41. Proprietary study. Property of Cargill. 2005.

J Nutr.136:415-420, 2006 www.nutrition.org.

43. Wang ZQ et al. "Effect of chromium picolinate on AMP-activated protein kinase alpha subunits and acetyl coenzyme A carboxylase in primary cultured human skeletal muscle cells." Abstract 24, A11. Presented at European Association for the Study of Diabetes annual meeting, 2005.

44. Anderson RA et al. "Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes." . 46, 11:1786-91, 1997. http://diabetes.diabetesjournals.org/

45. Komorowski JR et al. "Effect of chromium picolinate and biotin combination as an adjunctive nutritional therapy in poorly-controlled patients with diabetes mellitus." Abstract 749, PS 61 Nutrition and Diet II.. Presented at European Association for the Study of Diabetes annual meeting, 2005.

46. Yasmin T et al. "Toxicological Assessment Of A Novel Niacin-Bound Chromium, Known To Ameliorate The Symptoms Of Metabolic Syndromes" J Am Coll Nutr, 45th Annual Meeting, abs. 77, October, 2004.

47. Preuss HG et al. "Long-term effects of chromium, grape seed extract and zinc on various metabolic parameters of rats." Mol Cell Biochem. 223, 1-2:95-102, 2001. www.wkap.nl

48. Belhall KM et al. Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. Am J Clin Nutr. 80, 5:1185-93, 2004.

49. Slavin J et al. Practical dose of concentrated beta-glucans from oats improves blood lipid profile. Presented at the Experimental Biology Conference in April, 2005. www.nurtureinc.com

50. Din JN, Newby DE, Flapan AD. "Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment." BMJ. 328:30-5, 2004.http://bmj.com

51. Woodman RJ et al. "Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive Type II diabetic patients." Atherosclerosis. 166, 1:85-93, 2003. www.elsevier.com/locate/atherosclerosis

52. Rasmussen BM et al. "Effects of dietary saturated, monounsaturated, and n3 fatty acids on blood pressure in healthy subjects." Amer J Clin Nutr. 83, 2:221-6, 2006. www.ajcn.org

53. Moon YS, Kashyap ML. "Niacin extended-release/lovastatin: combination therapy for lipid disorders." Expert Opin Pharmacother. 3, 12:1763-71, 2002.

54. Morgan JM et al. "The effects of niacin on lipoprotein subclass distribution." Prev Cardiol. 7, 4:182-9, 2004.www.lejacq.com/preventive.cfm

55. Schnyder G et al. "Effect of homocysteine-lowering therapy with folic acid, vitamin B12 and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial." JAMA. 288, 8:973-9, 2002. http://jama.ama-assn.org/

56. Kurl S et al. "Plasma vitamin C modifies the association between hypertension and risk of stroke." Stroke. 33, 6:1568-73, 2002.http://stroke.ahajournals.org/

57. Ullegaddi R et al. Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke. Eur J Clin Nutr. 59, 12:1367-73, 2005. www.nature.com/ecjn/

58. Rao AV. "Lycopene, tomatoes and the prevention of coronary heart disease." Exp Biol Med (Maywood). 227, 10:908-13, 2002.

59. Yamamoto J et al. Tomatoes have natural anti-thrombotic effects. Br J Nutr. 90, 6:1031-38, 2003. www.nutritionsociety.org.uk/bjn/

60. Nagyova A et al. "Lipid peroxidation in men after dietary supplementation with a mixture of antioxidant nutrients." Bratisl Lek Listy. 105, 7-8:277-80, 2004.
http://www2.us.elsevierhealth.com/scripts/om.dll/serve?action=searchDB&searchDBfor=home&id=hj

61. Wei WQ et al. "Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke and total death." Am J Clin Nutr. 79, 1:80-5, 2004. www.ajcn.org

62. Gums JG. "Magnesium in cardiovascular and other disorders." Am J Health Syst Pharm. 61, 15:1569-76, 2004.

63. Rosenfeldt F et al. "Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure." Biofactors. 18, 1-4:91-100, 2003. www.iospress.nl/site/html/09516433.html

64. Sarter B. "Coenzyme Q10 and cardiovascular disease: a review." J Cardiovasc Nurs. 16, 4:9-20, 2002.

65. Singh RB et al. "Effect of coenzyme Q10 on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits." Atherosclerosis. 148, 2:275-82, 2000. www.elsevier.com/locate/atherosclerosis

66. Tran MT et al. "Role of coenzyme Q10 in chronic heart failure, angina and hypertension." Pharmacotherapy. 21, 7:797-806, 2001.www.iospress.nl/site/html/02770008.html

67. Noguchi T et al. "Nutritional prevention on hypertension, cerebral hemodynamics and thrombosis in stroke-prone spontaneously hypertensive rats." Cell Mol Neurobiol. 24, 5:599-638, 2004.

68. Cui J et al. "Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts." Mol Cell Biochem. 254, 1-2:227-34, 2003. www.wkap.nl

69. Kurowska EM and Manthey JA. "Hypolipidemic effects and absorption of citrus polymethoxylated flavones in hamsters with diet-induced hypercholesterolemia." J Agric Food Chem. 52, 10:2879-86, 2004.http://pubs.acs.org/journals/jafcau

70. Zhan S and Ho S. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Amer J Clin Nutr. 81, 2:397-408, 2005.www.ajcn.org

71. Ackermann RT et al. "Garlic shows promise for improving some cardiovascular risk factors." Arch Intern Med. 161, 6:813-24, 2001.http://archinte.ama-assn.org

72. Wang X et al. The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL. Atherosclerosis. 172, 2:239-46, 2004.http://www.sciencedirect.com/science/journal/00219150 

73. Wood RJ et al. Grape Polyphenols Exert a Cardioprotective Effect in Pre- and Postmenopausal Women by Lowering Plasma Lipids and Reducing Oxidative Stress. J Nutr. 135:1911-17, 2005. www.nutrition.org 

74. Engler MB and Engler MM. "The vasculoprotective effects of flavonoid-rich cocoa and chocolate." Nutr Res. 24, 9:695-706, 2004.www.elsevier.nl/locate/nutres

75. Vinson JA, Teufel K, Wu N. "Green and black teas inhibit atherosclerosis by lipid, antioxidant and fibrinolytic mechanisms." J Agric Food Chem. 52, 11:3661-5, 2004. http://pubs.acs.org/journals/jafcau

76. Chyu KY et al. "Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice." Circulation. 109, 20:2448-53, 2004. http://circ.ahajournals.org/

77. Buijsse B et al. "Cocoa Intake, Blood Pressure, and Cardiovascular Mortality: The Zutphen Elderly Study." Arch Intern Med. 166, 4:411-7, 2006. http://archinte.ama-assn.org/

78. Pearson L et al. Microsomal Triglyceride Transfer Protein Gene Expression and ApoB Secretion Are Inhibited by Bitter Melon in HepG2 Cells. J Nutr, 135, 4:702-6, 2005. www.nutrition.org

79. Aviram M et al. "Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice." Am J Clin Nutr. 71, 5:1062-76, 2000. www.ajcn.org

80. Sumner MD et al. Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. Am J Cardiol. 96, 6:810-4, 2005. www.ajconline.org

81. Moruisi KG et al. "Phytosterols/Stanols Lower Cholesterol Concentrations in Familial Hypercholesterolemic Subjects: A Systematic Review with Meta-Analysis." J Amer Coll Nutr. 25, 1:41-48, 2006.www.jacn.org

82. Gazzaruso C et al. "Relationship Between Erectile Dysfunction and Silent Myocardial Ischemia in Apparently Uncomplicated Type 2 Diabetic Patients." Circulation. 110:22-26, 2004. http://circ.ahajournals.org/

83. Thompson IM et al. "Erectile dynsfunction and subsequent cardiovascular disease." JAMA. 294, 23:2996-3002, 2005.http://jama.ama-assn.org/

84. IBID..

Eur J Pharmacol. 294(2-3):505-10, 1995.

86. Kim NN et al. "Role of arginase in the male and female sexual arousal response." J Nutr. 134(10 Suppl):2873S-2879S; discussion 2895S, 2004. Review. www.nutrition.org

87. Lebret T et al. "Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunction." Eur Urol. 41, 6:608-13; discussion 613, 2002.www.sciencedirect.com

88. McKay D. "Nutrients and botanicals for erectile dysfunction: examining the evidence." Altern Med Rev. 9, 1:4-16, 2004.www.thorne.com/altmedrev/.fulltext/9/1/4.pdf

89. Hong B et al. "A Double-Blind Crossover Study Evaluating the Efficacy of Korean Red Ginseng in Patients With Erectile Dysfunction: A Preliminary Report." 168, 5:2070-3, 2002. www.jurology.com

90. Trebaticky B et al. "Lipid metabolism and erectile function improvement by pycnogenol^®, extract from the bark of pinus pinaster in patients suffering from erectile dysfunction-a pilot study." Nutr Res. 23, 9:1189-98, 2003. http://www.sciencedirect.com/science/journal/02715317

91. Cavallini G et al. "Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging." Urology. 63, 4:641-6, 2004. www.sciencedirect.com

92. Agarwal A, Said TM. "Carnitines and male infertility." Reprod Biomed Online. 8, 4:376-84, 2004. http://dandini.ingentaselect.com

93. Vicari E et al. "Antioxidant therapeutic efficiency after the use of carnitine in infertile patients with bacterial or non bacterial prostato-vesiculo-epididymitis." Arch Ital Urol Androl. 73, 1:15-25, 2001.

94. A. Lenzi et al. "Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial." Fertil Steril. 79, 2:292-300, 2003. www.sciencedirect.com

95. Soufir JC et al. "Levels of seminal free L(-) carnitine in fertile and infertile men." Int J Androl. 7, 3:188-97, 1984.

96. Cavallini G et al. "Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging." Urology. 63, 4:641-6, 2004. www.sciencedirect.com

97. Gonzales GF et al. "Red maca (Lepidium meyenii) reduced prostate size in rats." Reprod Biol Endocrinol. 3, 1:5, 2005 [Epub ahead of print].

98. Gonzales GF et al. "Lepidium meyenii (Maca) improved semen parameters in adult men." Asian J Androl. 3, 4:301-3, 2001. www.asiaandro.com/1008-682X/3/301.htm

99. Gonzales GF et al. "Effect of Lepidium meyenii (Maca) on spermatogenesis in male rats acutely exposed to high altitude (4340 m)." J Endocrinol. 180, 1:87-95, 2004. http://joe.endocrinology.journals.org

100. Gonzales GF et al. "Effect of Lepidium meyenii (maca) roots on spermatogenesis of male rats." Asian J Androl. 3, 3:231-3, 2001. www.asiaandro.com/1008-682X/3/231.htm

101. Gonzales GF et al. "Effect of alcoholic extract of Lepidium meyenii (Maca) on testicular function in male rats." Asian J Androl. 5, 4:349-52, 2003. www.asiaandro.com/1008-682X/5/349.htm

102. Ang HH et al. "Effect of Eurycoma longifolia Jack on libido in middle-aged male rats." J Basic Clin Physiol Pharmacol. 13, 3:249-54, 2002.

103. Ang HH et al. "Aphrodisiac evaluation in non-copulator male rats after chronic administration of Eurycoma longifolia Jack." Fundam Clin Pharmacol. 15, 4:265-8, 2001. www.blackwell-synergy.com

104. Ang HH et al. ""Effects of Eurycoma longifolia Jack (Tongkat Ali) on the initiation of sexual performance of inexperienced castrated male rats." Exp Anim. 49, 1:35-8, 2000.

105. Ang HH et al. "Effects of Eurycoma longifolia Jack on laevator ani muscle in both uncastrated and testosterone-stimulated castrated intact male rats." Arch Pharm Res. 24, 5:437-40, 2001.

106. Brass EP. "Supplemental carnitine and exercise." Am J Clin Nutr. 72, (2 Suppl):618S-23S, 2000. www.ajcn.org

107. Volek JS. "L-carnitine L-targrate supplementation favorably affects markers of recovery from exercise stress." Am J Physiol Endocinol Metab. 282: E474-482, 2002. www.ajpendo.org

108. Wutzke KD et al. "The effect of L-carnitine on fat oxidation, protein turnover, and body composition in slightly overweight subjects." Metabolism.53, 8:1002-1006, 2004. www.sciencedirect.com/science/journal/00260495

109. Dodd SL et al. "The role of ribose in human skeletal muscle metabolism."Med Hypotheses. 62, 5:819-24, 2004.

110. Van Gammeren D et al. "The effects of four weeks of ribose supplementation on body composition and exercise performance in healthy, young male recreational bodybuilders: a double-blind, placebo-controlled trial." Curr Ther Res. 63, 8:486-95, 2002.

111. Ylikoski T et al. "The effect of coenzyme Q10 on the exercise performance of cross-country skiers." Mol Aspects Med. 18 Suppl:S283-90, 1997. www.sciencedirect.com/science/journal/00982997

112. Lima WP et al. "Lipid metabolism in trained rats: effect of guarana (Paullinia cupana Mart.) supplementation." Clin Nutr. 24,6:1019-28, 2005. http://www.sciencedirect.com/science/journal/02615614

113. Miura T et al. "Effect of guarana on exercise in normal and epinephrine-induced glycogenolytic mice." Biol Pharm Bull. 21, 6:646-8, 1998.

114. Manore MM. "Effect of physical activity on thiamine, riboflavin, and vitamin B-6 requirements." Am J Clin Nutr. 72, (2 Suppl):598S-606S, 2000. www.ajcn.org

115. Howlett KF et al. Carbohydrate metabolism during exercise in females: effect of reduced fat availability. Metabolism. 50(4):481-7, 2001. http://www.sciencedirect.com/science/journal/00260495

116. Murphy AJ et al. "Effects of creatine supplementation on aerobic power and cardiovascular structure and function." J Sci Med Sport. 8, 3:305-13, 2005.

117. Chilibeck PD et al. "Effect of creatine ingestion after exercise on muscle thickness in males and females." Med Sci Sports Exerc. 36, 10:1781-8, 2004. www.ms-se.com/

118. Motyka M. Magnesium creatine chelate. Newest concept in ergogenics. Agro-Food-Industry Hi-Tech. March/April 2001: 18-21. www.teknoscienze.com.

119. Paddon-Jones D et al, "Short-term beta-hydroxy-beta-methylbutyrate supplementation does not reduce symptoms of eccentric muscle damage." Int J Sport Nutr Exerc Metab. 11, 4:442-50, 2001. www.humankinetics.com

120. Bohl CH et al. "Magnesium and exercise." Crit Rev Food Sci Nutr. 42, 6:533-63, 2002.

121. Brotherhood JR. "Nutrition and sports performance." Sports Med. 1, 5:350-89, 1984.

122. Bohl CH et al. "Magnesium and exercise." Crit Rev Food Sci Nutr. 42, 6:533-63, 2002.

123. Lukaski HC. "Vitamin and mineral status: effects on physical performance." Nutrition. 20, (7-8):632-44, 2004. www.sciencedirect.com/science/journal/08999007

124. Davis JM et al. "Effects of carbohydrate and chromium ingestion during intermittent high-intensity exercise to fatigue." Int J Sport Nutr Exerc Metab. 10, 4:476-85, 2000. www.humankinetics.com

125. Frank LL and Baer JT. "The effect of a chromium-containing beverage on sprint cycling performance after a submaximal exercise bout." Med Sci Sports Exer. 34, 5 Supp:S3, 2002. http://www.acsm-healthfitness.org

126. Vincent JB et al. "The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent." Sports Med. 33, 3:213-30, 2003.

127. Crawford V et al. "Effects of niacin-bound chromium supplementation on body composition in overweight African-American women." Diabetes Obes Metab. 1, 6:331-7, 1999. www.blackwell-synergy.com

128. Godard MP et al. "Body composition and hormonal adaptations associated with forskolin consumption in overweight and obese men." Obes Res. 1, 38:1335-43, 2005. www.obesityresearch.org

129. Hedrei P et al. "Thermogenic Effect of Beta-sympathicomimetic Compounds Extracted From Citrus Aurantium In Humans." [Online] Available www.nutratechinc.com, Dec. 1, 2005.

130. Gougeon R et al. "Increase in the thermic effect of food in women by adrenergic amines extracted from citrus aurantium." Obes Res. 13, 7:1187-94, 2005

131. Ogden CL et al. "Prevalence of overweight and obesity in the United States, 1999-2004."
JAMA. 295, 13:1549-55, 2006. http://jama.ama-assn.org/

132. Bobyleva V et al. "The effects of the ergosteroid 7-oxo-dehydroepiandrosterone on mitochondrial membrane potential: possible relationship to thermogenesis." Arch Biochem Biophys. 341(1):122-8, 1997.

133. Zenk JL et al. "A prospective, randomized, double blind, placebo controlled study to evaluate the effect of 3-acetyl-7-oxo-DHEA on resting metabolic rate in overweight adult men and women on a coalorie restricted diet." Presented at the annual meeting of FASEB in 2004. http://select.biosis.org/faseb/eb2004_data/FASEB009299.html

134. Zenk JL et al. "The effect of 7-Keto Naturalean on weight loss: A randomized, double-blind, placebo-controlled trial." Curr Ther Res. 63, 4:263-72, 2002. http://www.sciencedirect.com/science/journal/0011393X

135. Kaiman DS et al. "A Randomized, double blind placebo controlled study of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy over weight adults." Curr Ther Res. 61, 7:435-42, 2000. http://www.sciencedirect.com/science/journal/0011393X

136. Dulloo AG et al. "Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans." Am J Clin Nutr. 70, 6:1040-5, 1999. www.ajcn.org

137. Shimotoyodome A et al. "Exercise and green tea extract stimulate fat oxidation and prevent obesity in mice." Med Sci Sports Exerc. 37, 11:1884-92, 2005. http://meta.wkhealth.com/

138. Murase T et al. "Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice." Am J Physiol Regul Integr Comp Physiol. 288(3):R708-15, 2005. http://ajpregu.physiology.org

139. Westerterp-Plantenga MS et al. "Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation."Obes Res. 13, 7:1195-204, 2005. www.obesityresearch.org

140. Wigham L et al. "Safety profile of conjugated linoleic acid in a 12-month trial in obese humans." Food Chem Toxicol. 42, 10:1701-1709, 2004.

141. Wang Y et al. "Dietary conjugated linoleic acid and body composition."Am J Clin Nutr. 79, (6 Suppl):1153S-1158S, 2004. www.ajcn.org.

142. Gaullier J et al. "Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans." Am J Clin Nutr. 79, 6:1118-25, 2004. www.ajcn.org.

143. Von Loeffelholz J et al. "Influence of conjugated linoleic acid body composition." European Journal of Lipid Science and Technology. 105:251-259, 2003. http://www3.interscience.wiley.com/cgi-bin/jhome/69502350

144. Voces J et al. "Ginseng administration protects skeletal muscle from oxidative stress induced by acute exercise in rats." Braz J Med Biol Res. 37, 12:1863-71, 2004. http://www.scielo.br/scielo.php?pid=0100-879X&script=sci_serial

145. Itoh H et al. "Vitamin E supplementation attenuates leakage of enzymes following 6 successive days of running training." Int J Sports Med. 21, 5:369-74, 2000. http://www.thieme.de/fz/sportsmed/

146. Takanami Y et al. "Vitamin E supplementation and endurance exercise: are there benefits?" Sports Med 29, 2:73-83, 2000. http://www.ingentaconnect.com/content/adis/smd

147. Tauler P et al. "Influence of vitamin C diet supplementation on endogenous antioxidant defences during exhaustive exercise." Pflugers Arch. 446, 6:658-64. Epub 2003 Jul 12, 2003.

148. Thompson D et al. "Prolonged vitamin C supplementation and recovery from demanding exercise." Int J Sport Nutr Exerc Metab. 11, 4:466-81, 2001. http://www.humankinetics.com/IJSNEM/journalAbout.cfm

149. Braham R et al. "The effect of glucosamine supplementation on people experiencing regular knee pain." Br J Sports Med. 37:45-9, 2003. http://bjsm.bmjjournals.com/

150. Uebelhart D et al. " Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo." Osteoarthr Cartil. 12, 4:269-76, 2004. www.sciencedirect.com/science/journal/10634584

151. Clegg DO et al. "Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis." NEJM. 354, 8:795-808, 2006. http://content.nejm.org

152. Clinicaltrials.gov, National Institutes of Health. "Glucosamine Unum In Die [Once A Day] Efficacy (GUIDE) Trial: Glucosamine Sulfate in Patients With Knee Osteoarthritis." [Online] Available Jan. 1, 2006.

153. Gupta R et al. Therapeutic efficacy and safety of glycosated undenatured type II collagen derivative (UC-II) in arthritic dogs. Presented at Society of Toxicology Annual Meeting, 2005.

154. Oesser S and Seifert J. Stimulation of type II collagen biosynthesis and secretion in bovine chondrocytes cultured with degraded collagen. Cell Tissue Res. 311, 3:393-9, 2003. www.springeronline.com

155. Moskowitz RW. Role of collagen hydrolysate in bone and joint disease.Semin Arthritis Rheum. 30, 2:87-99, 2000. http://journals.elsevierhealth.com

156. Kalman DS et al. A randomised double-blind clinical pilot trial evaluating the safety and efficacy of hydrolysed collagen type II in adults with osteoarthritis. FASEB. LB435:A90, 2004. www.fasebj.org

157. Hesslink R et al. Cetylated fatty acids improve knee function in patients with osteoarthritis. J Rheumatol. 29, 8:1708-12, 2002. www.jrheum.com

158. Kraemer WJ et al. Effect of a cetylated fatty acid topical cream on functional mobility and quality of life of patients with osteoarthritis. J Rheumatol. 31, 4:767-74, 2004. www.jrheum.com

159. Ratamass NA et al. Effects of treatment with a cetylated fatty acid topical cream on static postural stability and plantar pressure distribution in patients with knee osteoarthritis. J Strength Cond Res. 19, 1:115-21, 2005. http://nsca.allenpress.com

160. Zenk JL et al. "The effects of milk protein concentrate on the symptoms of osteoarthritis in adults: an exploratory, randomized, double blind, placebo-controlled trial." Curr Ther Res. 63, 7:430-42, 2002. www.currenttherapeuticres.com.

161. "E.T.S. (Extreme Training Support)." At-Large Nutrition [Online] Available http://www.atlargenutrition.com/nutrition_detail.php/products_id/5, Feb. 10, 2004

162. Kwiatkowski F et al. "[Stress, cancer and circadian rhythm of melatonin.]" Pathol Biol (Paris). 53, 5:269-72, 2005.

163. [No authors listed]. "[Effect of melatonin on the glucocorticoid-induced immunity suppression studied in vitro.]" Eksp Klin Farmakol. 68, 1:45-7, 2005.

164. Held K et al. "Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans." Pharmacopsychiatry. 35, 4:135-43, 2002. www.thieme.de/pharmaco

165. Golf SW, Bender S, Gruttner J. "On the significance of magnesium in extreme physical stress." Cardiovasc Drugs Ther. 12 Suppl 2:197-202, 1998. www.kluweronline.com/issn/0920-3206/current

166. Prager N et al. "A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia." J Altern Compl Med. 8, 2:143-52, 2002. http://www.liebertonline.com/loi/acm

167. Proprietary study. Actaris Inc.. www.acatris.com

168. Andriole G et al. "Dihydrotestosterone and the prostate: the scientific rationale of 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia." J Urol. 172, 4:1399-403, 2004.

169. Comhaire F and Mahmoud A. "Preventing diseases of the prostate in the elderly using hormones and nutriceuticals." Aging Male. 7, 2:155-69, 2004.

170. Wilt TJ et al. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA. 1998; 280, 18:16041609, 1998.http://jama.ama-assn.org/

171. Ishani A et al. Serenoa repens for benign prostatic hyperplasia. Cochr Data Syst Rev. 3:CD001423, 2002.

172. Choo MS et al. "Functional evaluation of Tadenan on micturition and experimental prostate growth induced with exogenous dihydrotestosterone."Urology. 55, 2:292-8, 2000. http://www.sciencedirect.com/science/journal/00904295

173. Friederich M et al. "Prosta Fink Forte capsules in the treatment of benign prostatic hyperplasia. Multicentric surveillance study in 2245 patients."Forsch Komplementarmed Klass Naturheilkd 7:200-4, 2000. [in German].

174. Kucuk O et al. Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med. (Maywood). 227, 10:881-5, 2002. www.ebmonline.org.

175. Takada Y et al. "Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappaB and NF-kappaB-regulated gene expression." J Immunol. 176, 5:3127-40, 2006.

176. Malik A et al. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci. 102, 41:14813-8, 2005. www.pnas.org

177. Hsing AW et al. "Allium vegetables and risk of prostate cancer: a population-based study." J Natl Cancer Inst. 94, 21:1648-51, 2002. http://jncicancerspectrum.oupjournals.org/jnci.

178. Lee MM et al. Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev. 12, 7:665-8, 2003. http://cebp.aacrjournals.org.

179. Durak I et al. Consumption of aqueous garlic extract leads to significant improvement in patients with benign prostate hyperplasia and prostate cancer. Nutr Res. 23, 2:199-204, 2003. www.elsevier.com/locate/issn/02715317.

180. Bylund A et al. Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate. 42, 4:304-14, 2000. www.wileyeurope.com/WileyCDA/WileyTitle/productCd-PROS.html.

181. Hedelin M et al. "Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the Cancer Prostate Sweden Study." Cancer Cause Control. 17:169-80, 2006.

182. Bylund A et al. "Anticancer effects of a plant lignan 7-hydroxymatairesinal on a prostate cancer model in vivo." Exp Biol Med (Maywood). 230, 3:217-23, 2005.

183. Malafa MP et al. "Vitamin E succinate suppresses prostate tumor growth by inducing apoptosis." Int J Cancer. 118, 10:2441-7, 2006. http://www3.interscience.wiley.com/cgi-bin/jhome/29331

184. Fitzgerald JM et al. Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control. 16, 9:1125-31, 2005. www.springerlink.com/link.asp?id=100150

185. Waters DJ et al. Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. J Natl Cancer Inst. 95, 3:237-41, 2003. http://jncicancerspectrum.oupjournals.org/jnci.

186. Cao S et al. "Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts." Clin Cancer Res. 10, 7:2561-9, 2004. http://clincancerres.aacrjournals.org

187. Fakih MJ et al. "A phase I and pharmacokinetic study of fixed-dose selenomethionine and irinotecan in solid tumors." Clin Cancer Res. 12, 4:1237-44, 2006. http://clincancerres.aacrjournals.org

188. Reid ME et al. "Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial." Inl J Cancer. 118, 7:1777-81, 2006.

189. Peters U et al. "High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program." Cancer Epidemiol Biomarkers Prev. 15, 2:315-20, 2006. http://cebp.aacrjournals.org

190. Sharma RA et al. "Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance." Clin Cancer Res. 10:6847-54, 2004.

191. Femia AP. "Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats." Carcinogenesis. 23, 11:1953-60, 2002. http://carcin.oupjournals.org

192. Delzenne N. "Prebiotics: actual and potential effects in inflammatory and malignant colonic diseases." Curr Opin Clin Nutr Metab Care. 6, 5:581-6, 2003. www.ncbi.nih.gov

193. Center SA et al. "The effects of S-adenosylmethionine on clinical pathology and redox potential in the red blood cell, liver, and bile of clinically normal cats." J Vet Intern Med. 19, 3:303-14, 2005.

194. Caro AA et al. "Antioxidant properties of S-adenosyl-L-methionine in Fe(2+)-initiated oxidations." Free Radic Biol Med.36, 10:1303-16, 2004.

195. Song Z et al. "Modulation of endotoxin stimulated interleukin-6 production in monocytes and Kupffer cells by S-adenosylmethionine (SAMe)."Cytokine. 28, 6:214-23, 2004.

196. Lieber CS et al. "New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments." Curr Gastroenterol Rep. 6, 1:60-5, 2004.

197. Krueger KJ et al. "Nutritional supplements and alternative medicine." Curr Opin Gastroenterol. 20, 2:130-8, 2004.

198. Arteel G et al. "Advances in alcoholic liver disease." Best Pract Res Clin Gastroenterol. 17, 4:625-47, 2003.

199. Wu DF et al. "[The effects of silymarin on hepatic microsomal and mitochondrial membrane fluidity in mice]." Zhongguo Zhong Yao Za Zhi. 28, 9:870-2, 2003.

200. Boerth J et al. "The clinical utility of milk thistle (Silybum marianum) in cirrhosis of the liver." J Herb Pharmacother. 2, 2:11-7, 2002.

201. Lieber CS et al. "Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons." J Clin Gastroenterol. 37, 4:336-9, 2003.

202. Saller R et al. "The use of silymarin in the treatment of liver diseases." Drugs. 61, 14:2035-63, 2001.

203. Zaidi SM. "Effects of antioxidant vitamins on glutathione depletion and lipid peroxidation induced by restraint stress in the rat liver." Drugs R D. 6, 3:157-65, 2005.

204.

205. Semba RD, Dagnelie G. "Are lutein and zeaxanthin conditionally essential nutrients for eye health?" Med Hypotheses. 61, 4:465-72, 2003. www.harcourt-international.com/journals/mehy

206. Johnson EJ. "Obesity, lutein metabolism and age-related macular degeneration: a web of connections." Nutr Rev. 63, 1:9-15, 2005. www.ilsi.org/publications/reviews.html

207. Richer S et al. "Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial)." Optometry. 75, 4:216-30, 2004.

208. Koh HH et al. "Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study." Exp Eye Res. 79:21-7, 2004.

209. Thomson LR et al. "Elevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quail." Invest Ophthalmol Vis Sci. 43, 11:3538-49, 2002. www.iovs.org

210. Sackett CS, Schenning S. "The age-related eye disease study: the results of the clinical trial." Insight. 27, 1:5-7, 2002.

211. Hogg , Chakravarthy U. "AMD and micronutrient antioxidants." Curr Eye Res. 29, 6:387-40, 2004.

212. Chylack LT Jr et al. "The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract."Ophthalmic Epidemiol. 9, 1:49-80, 2002.

213. Hegde KR, Varma SD. "Protective effect of ascorbate against oxidative stress in the mouse lens." Biochim Biophys Acta. 1670, 1:12-8, 2004.www.elsevier.nl/locate/bba

214. Ayala MN, Soderberg PG. "Vitamin E can protect against ultraviolet radiation-induced cataract in albino rats." Ophthalmic Res. 36, 5:264-9, 2004. www.karger.com/journals/ore/ore_jh.htm

215. Gupta SK et al. "Lycopene attenuates oxidative stress induced experimental cataract development: an in vitro and in vivo study." Nutrition. 19, 9:794-9, 2003. www.journals.elsevierhealth.com/periodicals/nut

216. Wu TH et al. "An astaxanthin-containing algal extract attenuates selenite-induced nuclear cataract formation in rat pups." Experimental Biology, 2002.

217. Gupta SK et al. "Green tea (Camellia sinensis) protects against selenite-induced oxidative stress in experimental cataractogenesis." Ophthalmic Res. 34, 4:258-63, 2002. www.karger.com/journals/ore/ore_jh.htm

218. Canter PH, Ernst E. "Anthocyanosides of Vaccinium myrtillus (bilberry) for night vision--a systematic review of placebo-controlled trials." Surv Ophthalmol. 49, 1:38-50, 2004.

219. Schonlau F, Rohdewald P. "Pycnogenol for diabetic retinopathy: a review." Int Ophthalmol. 24, 3:161-71, 2001.

220. Nakaishi H et al. "Effects of black currant anthocyanoside intake on dark adaptation and VDT work-induced transient refractive alteration in healthy humans." Altern Med Rev. 5, 6:553-62, 2000. www.thorne.com/altmedrev

221. Thiagarajan G et al. "Molecular and cellular assessment of ginkgo biloba extract as a possible ophthalmic drug." Exp Eye Res. 75, 4:421-30, 2002.